These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8027977)

  • 1. Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents.
    Anderson WK; Gopalsamy A; Reddy PS
    J Med Chem; 1994 Jun; 37(13):1955-63. PubMed ID: 8027977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.
    Jurayj J; Haugwitz RD; Varma RK; Paull KD; Barrett JF; Cushman M
    J Med Chem; 1994 Jul; 37(14):2190-7. PubMed ID: 8035426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
    Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
    Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives.
    Moron J; Rautureau M; Huel C; Pierré A; Berthier LK; Atassi G; Bisagni E
    Anticancer Drug Des; 1993 Dec; 8(6):399-416. PubMed ID: 8286009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells.
    Vistica DT; Kenney S; Hursey ML; Boyd MR
    Biochem Biophys Res Commun; 1994 May; 200(3):1762-8. PubMed ID: 8185636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise synthesis and antiproliferative activity evaluation of ellipticine quinone and its analogs.
    Nishiyama T; Hatae N; Mizutani M; Yoshimura T; Kitamura T; Miyano M; Fujii M; Satsuki N; Ishikura M; Hibino S; Choshi T
    Eur J Med Chem; 2017 Aug; 136():1-13. PubMed ID: 28477443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.
    Shi LM; Fan Y; Myers TG; O'Connor PM; Paull KD; Friend SH; Weinstein JN
    J Chem Inf Comput Sci; 1998; 38(2):189-99. PubMed ID: 9538518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
    Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
    J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor evaluation of cis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and -uridine analogues.
    Kim JC; Lee MH; Choi SK
    Arch Pharm Res; 1998 Aug; 21(4):465-9. PubMed ID: 9875477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
    Acton EM; Narayanan VL; Risbood PA; Shoemaker RH; Vistica DT; Boyd MR
    J Med Chem; 1994 Jul; 37(14):2185-9. PubMed ID: 8035425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 5-aza-ellipticine derivatives.
    Moody DL; Dyba M; Kosakowska-Cholody T; Tarasova NI; Michejda CJ
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2380-4. PubMed ID: 17376678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).
    Paoletti C; Le Pecq JB; Dat-Xuong N; Juret P; Garnier H; Amiel JL; Rouesse J
    Recent Results Cancer Res; 1980; 74():107-23. PubMed ID: 7003658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
    Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basically substituted ellipticine analogues as potential antitumor agents.
    Werbel LM; Angelo M; Fry DW; Worth DF
    J Med Chem; 1986 Jul; 29(7):1321-2. PubMed ID: 3806584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro stimulation by ellipticine derivatives of DNA cleavage induced by DNA topoisomerase II: a structure-activity relationship].
    Fossé P; Charra M; Paoletti C; Saucier JM; René B
    Bull Cancer; 1994 Mar; 81(3):194-202. PubMed ID: 7894127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide.
    Stiborová M; Sejbal J; Borek-Dohalská L; Aimová D; Poljaková J; Forsterová K; Rupertová M; Wiesner J; Hudecek J; Wiessler M; Frei E
    Cancer Res; 2004 Nov; 64(22):8374-80. PubMed ID: 15548707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
    El-Sayed WA; Rashad AE; Awad SM; Ali MM
    Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):261-74. PubMed ID: 20183580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
    Phadtare S; Kessel D; Corbett TH; Renis HE; Court BA; Zimlicka J
    J Med Chem; 1991 Jan; 34(1):421-9. PubMed ID: 1992143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a series of cytotoxic 2-acyl-1,2-dihydroellipticines which inhibit topoisomerase II.
    Devraj R; Jurayj J; Fernandez JA; Barrett JF; Cushman M
    Anticancer Drug Des; 1996 Jun; 11(4):311-24. PubMed ID: 8679054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.